A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
PHASE3
This is a phase 3 open-label, randomized, controlled, multicenter study to ...
Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments
N/A
Psoriatic arthritis (PsA) is an inflammatory joint disease that can also af...
Status
Not Yet Recruiting
Location
Bezmialem Vakif University
Start Date
2025-04-10
Trial ID
NCT06918886
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
PHASE3
This open-label study will evaluate the efficacy and safety of tocilizumab ...
A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis
N/A
This cross-sectional, non-interventional, retrospective chart review will c...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01866150
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
PHASE4
To investigate the effect of CTLA4-Ig (abatacept) on phenotype, transcripti...
A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
PHASE4
An interventional Phase 4 open-label, randomized, controlled, parallel-grou...